Is beta blockers suitable for all patients with coronary heart disease?

doi:10.3969/j.issn.1004-583X.2019.11.001

Abstract

Abstract: It was believed that the symptoms and prognosis of patients with coronary heart disease(CHD) could be improved by beta receptor blockers (BBs). However, more and more evidencebased medical study suggests that the impact of BBs is declining in the treatment of patients with CHD. Clinical studies in recent years have shown that patients with CHD without myocardial infarction or heart failure (or cardiac dysfunction) do not benefit from BBs treatment. In addition to heart failure, there was no evidence to support the lifelong application of BBs in patients with CHD. And increasing the dose of BBs did not bring additional benefits to patients with CHD. Revascularization (PCI) treatment reduces the need for BBs in patients with CHD. In this paper, the status change of BBs in the treatment of CHD in recent years is reviewed.

Key words: beta receptor blockers, coronary disease, myocardial infarction, heart failure

Wang Qian, Cui Wei. Is beta blockers suitable for all patients with coronary heart disease?[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2019.11.001.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2019.11.001

https://huicui.hebmu.edu.cn/EN/Y2019/V34/I11/965

[1]	Duan Fang, Cui Wei. Application principles of vasodilators in the treatment of acute heart failure [J]. Clinical Focus, 2023, 38(9): 773-778.
[2]	Wei Yuhan, Zhao Yanan, Zhang Guibin, Wu Yuqing, Dong Bohua, Hu Jiayuan, Yang Wenqi. Correlation analysis of monocyte-to-high density lipoprotein cholesterol ratio, red cell distribution width, and uric acid with the severity of coronary artery disease in patients with coronary heart disease [J]. Clinical Focus, 2023, 38(9): 796-801.
[3]	Zhang Canna, Xiang Lu, Luo Yaxiong. Electrocardiographic findings of the spiked helmet sign: A case report and literature review [J]. Clinical Focus, 2023, 38(5): 444-447.
[4]	Wang Zhen, Yang Xiaoyue, Li Shaojie, Wang Xian, Chen Shuxia, Gu Jian. Analysis of clinical characteristics and readmission risk factors in patients with ejection fraction preserved heart failure combined with atrial fibrillation [J]. Clinical Focus, 2023, 38(4): 308-314.
[5]	Yan Haiyan, Ding Yankui, JiaHongjing , WangJiyuan , Zhang Xuewei, Hu Yinjie, Chu Junjie, Hu Hongyan, Guo Gaofeng. Correlation of pre-hospital heparinization combined with one pack of drugs and revascularization in patients with acute ST-segment elevation myocardial infarction [J]. Clinical Focus, 2023, 38(3): 232-236.
[6]	Wang Jiaqi, Wang Wenjing, Liu Litian, Zhang Feifei, Dang Yi, Qi Xiaoyong. Acute myocardial infarction caused by spontaneous coronary artery dissection in a young woman: A case report and literature review [J]. Clinical Focus, 2023, 38(2): 162-165.
[7]	Li Nana, Jiang Shan. Predictive values of serum homocysteine, cystatin C and high sensitive C-reactive protein levels on heart failure after percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction [J]. Clinical Focus, 2023, 38(2): 121-125.
[8]	Zhang Fang, Zhang Yichao, Jia Xinwei, Li Jianlong, Chen Chunhong. Analysis of one-year follow-up results of ≥75-year-old atrial fibrillation inpatients with high CHA2DS2-VASc score [J]. Clinical Focus, 2023, 38(2): 117-120.
[9]	Yi Xin, Liu Canzhang, Liu Qiang, Wang Cong, Gao Teng, Yan Jie. Effects of anxiety and depression on the composition and properties of coronary plaque in patients with coronary heart disease [J]. Clinical Focus, 2023, 38(1): 50-54.
[10]	Zhang Shangshi, Zhu Hongyan, Li Nan, Chen Yingxi. Correlation between coronary artery lesion and insulin resistance in patients with coronary heart disease combined with type 2 diabetes mellitus [J]. Clinical Focus, 2023, 38(1): 46-49.
[11]	Zhang Jingshui, Xu Yanan, Wang Jun, Yang Yi, Jiang Haibing, Tang Long, Wang Xianping, Shao Mingliang. Clinical characteristics and long-term prognosis of initial patients with new onset different type of heart failure combined atrial fibrillation [J]. Clinical Focus, 2022, 37(6): 504-509.
[12]	Li Heng, Li Yonghui, Sun Xiaoqiang, Wang Lin, He Feng. Efficacy and safety of anticoagulant therapy for patients with heart failure in sinus rhythm [J]. Clinical Focus, 2022, 37(5): 406-411.
[13]	Wang Jiaqi, Gao Man, Zhang Feifei, Li Yingxiao, Dang Yi, Qi Xiaoyong. Predicting value of neutrophil to lymphocyte ratio combined with GRACE score on in-hospital major adverse cardiovascular events of postoperative PCI in acute STEMI patients [J]. Clinical Focus, 2022, 37(5): 412-417.
[14]	Wang Yajie, Lin Wenhua, Jing Rui, Liu Jingjing, Lu Yujie. The relationship between serum homocysteine levels and SYNTAX score in patients with non-ST-segment elevation myocardial infarction [J]. Clinical Focus, 2022, 37(4): 325-328.
[15]	Wang Runqing, Wang Qian, Liao Jianxiong. A network meta-analysis of SGLT2 inhibitors on cardiovascular outcomes in patients with type 2 diabetes [J]. Clinical Focus, 2022, 37(12): 1061-1073.

Is beta blockers suitable for all patients with coronary heart disease?

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments